Safety and Efficacy of Combining Intranasal Insulin & Acute Exercise
Conditions: Insulin; Exercise Interventions: Drug: Placebo into the intranasal mucosa; Drug: 20 IU NovoLog Insulin aspart into the intranasal mucosa; Drug: 40 IU NovoLog Insulin aspart into the intranasal mucosa; Drug: 60 IU NovoLog Insulin aspart into the intranasal mucosa; Drug: 80 IU NovoLog Insulin aspart into the intr anasal mucosa; Drug: 100 IU NovoLog Insulin aspart into the intranasal mucosa; Drug: 120 IU NovoLog Insulin aspart into the intranasal mucosa Sponsor: Michigan State University Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials